###begin article-title 0
Ribonucleoprotein Assembly Defects Correlate with Spinal Muscular Atrophy Severity and Preferentially Affect a Subset of Spliceosomal snRNPs
###end article-title 0
###begin p 1
Conceived and designed the experiments: LP. Performed the experiments: FG MB LS CC. Analyzed the data: AB LP FG MB LS CC. Contributed reagents/materials/analysis tools: AB MB. Wrote the paper: LP. Other: Coordinated the study: AB LP.
###end p 1
###begin p 2
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
###xml 1363 1367 <span type="species:ncbi:10090">mice</span>
Spinal muscular atrophy (SMA) is a motor neuron disease caused by reduced levels of the survival motor neuron (SMN) protein. SMN together with Gemins2-8 and unrip proteins form a macromolecular complex that functions in the assembly of small nuclear ribonucleoproteins (snRNPs) of both the major and the minor splicing pathways. It is not known whether the levels of spliceosomal snRNPs are decreased in SMA. Here we analyzed the consequence of SMN deficiency on snRNP metabolism in the spinal cord of mouse models of SMA with differing phenotypic severities. We demonstrate that the expression of a subset of Gemin proteins and snRNP assembly activity are dramatically reduced in the spinal cord of severe SMA mice. Comparative analysis of different tissues highlights a similar decrease in SMN levels and a strong impairment of snRNP assembly in tissues of severe SMA mice, although the defect appears smaller in kidney than in neural tissue. We further show that the extent of reduction in both Gemin proteins expression and snRNP assembly activity in the spinal cord of SMA mice correlates with disease severity. Remarkably, defective SMN complex function in snRNP assembly causes a significant decrease in the levels of a subset of snRNPs and preferentially affects the accumulation of U11 snRNP-a component of the minor spliceosome-in tissues of severe SMA mice. Thus, impairment of a ubiquitous function of SMN changes the snRNP profile of SMA tissues by unevenly altering the normal proportion of endogenous snRNPs. These findings are consistent with the hypothesis that SMN deficiency affects the splicing machinery and in particular the minor splicing pathway of a rare class of introns in SMA.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 296 299 296 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Crawford1">[1]</xref>
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Sumner1">[5]</xref>
###xml 908 912 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 999 1003 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 1009 1012 1009 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Lefebvre1">[6]</xref>
###xml 1072 1076 1072 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 1082 1086 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 1151 1154 1151 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Lorson1">[7]</xref>
###xml 1156 1159 1156 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani2">[8]</xref>
###xml 1276 1279 1272 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Lorson2">[9]</xref>
###xml 1303 1307 1299 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 1390 1394 1386 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 1416 1420 1412 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 1477 1481 1473 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-McAndrew1">[10]</xref>
###xml 1556 1560 1552 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Coovert1">[11]</xref>
###xml 1562 1566 1558 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Lefebvre2">[12]</xref>
###xml 510 518 <span type="species:ncbi:9606">patients</span>
###xml 830 838 <span type="species:ncbi:9606">patients</span>
###xml 1547 1555 <span type="species:ncbi:9606">patients</span>
Spinal muscular atrophy (SMA) is an autosomal recessive disorder characterized by degeneration of motor neurons in the spinal cord and skeletal muscle atrophy. SMA is the leading genetic cause of death in infancy and is classified into three types based on the age of onset and clinical severity [1]-[5]. Type I is the most severe and frequent form of SMA with disease onset before six months of age and death usually by the age of two. Type II is the intermediate form with onset prior to eighteen months and patients never gaining the ability to walk. Type III is the mild form characterized by onset after eighteen months with the ability to walk and a normal life expectancy. Very severe fetal-onset (type 0) and very mild adult-onset (type IV) forms of SMA have also been described. Irrespective of disease severity, all SMA patients have homozygous deletions or mutations in the survival motor neuron (SMN1) gene, the SMA-determining gene, and retain at least one copy of the nearly identical SMN2 gene [6]. A single nucleotide difference functionally distinguishes SMN1 from SMN2, affecting the amount of exon 7 inclusion in the SMN transcript [7], [8]. The loss of exon 7 removes the carboxy-terminal amino acids making SMNDelta7 protein unstable and rapidly degraded [9]. As a consequence, the SMN2 gene produces low levels of full-length SMN and cannot compensate for the loss of SMN1 in SMA. However, the SMN2 gene copy number acts as a modifier of disease severity [10], which inversely correlates with the levels of SMN expression in patients [11], [12].
###end p 4
###begin p 5
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN</italic>
###xml 310 313 310 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani1">[3]</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Butchbach1">[13]</xref>
###xml 447 450 447 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smn</italic>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Frugier2">[14]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Schrank1">[17]</xref>
###xml 579 583 579 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 602 605 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smn</italic>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-HsiehLi1">[15]</xref>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani3">[16]</xref>
###xml 754 758 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 850 854 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 895 899 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-HsiehLi1">[15]</xref>
###xml 901 905 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani3">[16]</xref>
###xml 1066 1070 1066 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 1126 1130 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani3">[16]</xref>
###xml 1272 1276 1268 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 1369 1373 1365 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Le1">[18]</xref>
###xml 1637 1641 1629 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani4">[19]</xref>
###xml 93 98 <span type="species:ncbi:4932">yeast</span>
###xml 102 108 <span type="species:ncbi:9606">humans</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 303 309 <span type="species:ncbi:9606">humans</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 477 482 <span type="species:ncbi:10090">mouse</span>
###xml 540 545 <span type="species:ncbi:9606">human</span>
###xml 573 578 <span type="species:ncbi:9606">human</span>
###xml 596 601 <span type="species:ncbi:10090">mouse</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 1121 1125 <span type="species:ncbi:10090">mice</span>
###xml 1298 1303 <span type="species:ncbi:10090">mouse</span>
###xml 1389 1393 <span type="species:ncbi:10090">mice</span>
###xml 1482 1487 <span type="species:ncbi:10090">mouse</span>
###xml 1598 1606 <span type="species:ncbi:9606">patients</span>
###xml 1656 1660 <span type="species:ncbi:10090">mice</span>
###xml 1930 1935 <span type="species:ncbi:9606">human</span>
###xml 1936 1944 <span type="species:ncbi:9606">patients</span>
###xml 1949 1954 <span type="species:ncbi:10090">mouse</span>
The SMN gene is ubiquitously expressed and is essential for viability in many organisms from yeast to humans. To understand SMA etiology and support therapeutics development, a number of different animal models of SMA have been created and SMA mice more closely resemble the feature of SMA pathology in humans [3], [13]. Distinct strategies have been employed to circumvent the early embryonic lethality associated with the knockout of the single Smn gene in mice and generate mouse models of SMA [14]-[17]. Similar to the situation in the human disease, expression of the human SMN2 gene in the mouse Smn null background rescues embryonic lethality and results in mice with SMA [15], [16]. Importantly, the severity of the phenotype is dependent on the SMN2 copy number. Severe SMA mice with a single SMN2 gene die embryonically while mice with two SMN2 copies survive on average for five days [15], [16]. These mice have reduced weight and severe motor impairment before appreciable loss of motor neuron cell bodies, which occurs at postnatal day 3. Eight or more SMN2 gene copies fully rescue the SMA phenotype in SMA mice [16]. Interestingly, introducing a SMNDelta7 transgene that encodes a SMN isoform lacking exon 7-which is the predominant isoform produced by the SMN2 gene-to a severe SMA mouse genetic background has moderately beneficial effects on survival [18]. SMNDelta7 SMA mice still display a considerably severe phenotype and die on average at two weeks of age. A mouse model of the mild form of SMA was generated by introducing SMN(A2G), a SMN point mutant found in type III SMA patients, to the severe SMA background [19]. SMN(A2G) SMA mice display very late onset of muscle weakness and motor impairment, moderate loss of motor neurons, and survive over one year. Collectively, these studies indicate that reduced SMN activity causes SMA and that disease severity inversely correlates with SMN levels in both human patients and mouse models.
###end p 5
###begin p 6
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Meister1">[20]</xref>
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Paushkin1">[21]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Pellizzoni1">[22]</xref>
###xml 882 886 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Matera1">[23]</xref>
###xml 1026 1030 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Pellizzoni1">[22]</xref>
###xml 1032 1036 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Matera1">[23]</xref>
###xml 1206 1210 1206 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Fischer1">[24]</xref>
###xml 1211 1215 1211 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Pellizzoni2">[26]</xref>
###xml 1387 1391 1387 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Carissimi1">[27]</xref>
###xml 1392 1396 1392 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Winkler1">[33]</xref>
###xml 1567 1571 1567 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Carrel1">[34]</xref>
###xml 1572 1576 1572 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Rossoll1">[37]</xref>
###xml 1793 1797 1793 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Zhang1">[38]</xref>
###xml 1799 1803 1799 1803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Zhang2">[39]</xref>
###xml 1963 1967 1960 1964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Rossoll1">[37]</xref>
###xml 1865 1869 <span type="species:ncbi:10090">mice</span>
The molecular defect responsible for motor neuron degeneration in SMA is unknown. SMN is a multifunctional protein that has been implicated in a variety of cellular processes, many of which are linked to RNA metabolism [20], [21]. It is well established that SMN associates with itself and at least eight additional proteins (Gemins2-8 and unrip) to form a macromolecular complex referred to as the SMN complex [22]. To date, the only molecularly defined cellular activity of the SMN complex is its function in the biogenesis of small nuclear ribonucleoproteins (snRNPs), the essential components of the pre-mRNA splicing machinery that catalyze the excision of introns from mRNA precursors in the nucleus. Spliceosomal snRNPs of the Sm class comprise an snRNA molecule (U1, U2, U4, U4atac, U5, U11 and U12), seven common Sm proteins and additional proteins specific for each snRNP [23]. The snRNP biogenesis pathway requires the activity of a number of auxiliary factors and takes place in both the nucleus and the cytoplasm [22], [23]. In the cytoplasm, the SMN complex mediates the ATP-dependent assembly of a heptameric ring of Sm proteins around a conserved sequence of the snRNAs to form the Sm core [24]-[26]. Consistent with the essential role for the SMN complex in snRNP assembly, reducing expression of either SMN or Gemin proteins in cultured cells affects Sm core formation [27]-[33]. It is, however, becoming increasingly clear that SMN may have additional functions in distinct cell types that are unrelated to snRNP biogenesis and are relevant to SMA [34]-[37]. A subset of SMN complexes that do not contain Sm proteins traffic into axons and growth cones of motor neurons and may be involved in some aspects of the axonal transport and localized translation of specific mRNAs [38], [39]. Accordingly, cultured primary motor neurons from severe SMA mice display reduced accumulation of beta-actin mRNA in growth cones and defective axon outgrowth [37].
###end p 6
###begin p 7
###xml 396 404 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Shpargel1">[31]</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Buhler1">[40]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Pellizzoni3">[41]</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Wan1">[32]</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Winkler1">[33]</xref>
###xml 833 837 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-McWhorter1">[35]</xref>
###xml 1030 1034 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Carrel1">[34]</xref>
###xml 1036 1040 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-McWhorter1">[35]</xref>
###xml 1167 1171 1167 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Winkler1">[33]</xref>
###xml 1396 1400 1396 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Gabanella1">[42]</xref>
###xml 1893 1903 1893 1903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1949 1953 1949 1953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Wan1">[32]</xref>
###xml 1955 1959 1955 1959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Rajendra1">[36]</xref>
###xml 2134 2141 2134 2141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2141 2145 2141 2145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Pellizzoni1">[22]</xref>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
###xml 446 451 <span type="species:ncbi:9606">human</span>
###xml 504 512 <span type="species:ncbi:9606">patients</span>
###xml 809 818 <span type="species:ncbi:7955">zebrafish</span>
###xml 855 864 <span type="species:ncbi:7955">zebrafish</span>
###xml 1378 1383 <span type="species:ncbi:10090">mouse</span>
###xml 1796 1803 <span type="species:ncbi:9031">chicken</span>
###xml 2390 2395 <span type="species:ncbi:10090">mouse</span>
###xml 2575 2579 <span type="species:ncbi:10090">mice</span>
###xml 2835 2839 <span type="species:ncbi:10090">mice</span>
One of the most pressing issues in SMA biology is whether deficiencies in snRNP biogenesis, axonal SMN function(s) or possibly even both are responsible for motor neuron degeneration in SMA. A link between deficiencies in snRNP biogenesis and SMA pathology is suggested by the observation that some SMN mutants of SMA patients display defective binding to Sm proteins and snRNP assembly activity in vitro[31], [40], [41]. Moreover, extracts from human fibroblast and lymphoblast cell lines of type I SMA patients have reduced snRNP assembly activity compared with normal controls [32]. To date, the most direct evidence that defects of snRNP metabolism may trigger motor neuron degeneration in SMA is that injection of snRNPs rescues motor axon outgrowth and pathfinding defects caused by knockdown of SMN in zebrafish embryos [33], [35]. Although in the zebrafish model system is important to distinguish whether motor axon defects are cell autonomous or secondary to general development defects which cause axonal abnormalities [34], [35], knockdown of two additional factors involved in the pathway of snRNP biogenesis reportedly also affects motor axon outgrowth [33]. These findings, together with the observation that SMN activity in snRNP assembly is very prominent during embryonic and early postnatal development but is strongly down regulated after myelination in the mouse spinal cord [42], suggest that developmental deficiencies in snRNP biogenesis may underlie motor neuron degeneration in SMA. According to this view, reduced SMN activity in snRNP assembly would affect the accumulation of snRNPs thereby weakening the splicing machinery. To date, however, there has been no evidence that snRNP levels are affected in SMA. Furthermore, endogenous snRNP levels are not decreased in chicken DT40 cells with markedly reduced SMN levels and impaired Sm core formation as well as in Drosophila larvae that harbor lethal SMN null mutations [32], [36]. These observations raise the issue as to whether snRNP assembly activity in SMA ever falls significantly below the threshold that would affect the steady-state snRNP levels in vivo[22]. Here, we sought to address the consequences of SMN deficiency on snRNP metabolism in the spinal cord, the target tissue of SMA. To do so, we analyzed SMN complex expression, Sm core formation activity and endogenous snRNP levels in tissues of mouse models of SMA. Our results indicate that disease severity correlates with the degree of impairment of SMN complex expression and snRNP assembly activity in the spinal cord of SMA mice. Remarkably, defective SMN complex function in snRNP assembly causes a significant decrease in the levels of a subset of spliceosomal snRNPs and preferentially affects the accumulation of U11 snRNP of the minor splicing pathway in tissues from severe SMA mice. Thus, SMN deficiency unevenly alters the physiological proportion of endogenous snRNPs in SMA.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 56 60 <span type="species:ncbi:10090">mice</span>
SMN complex expression in the spinal cord of severe SMA mice
###end title 9
###begin p 10
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 176 180 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 180 183 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 188 191 188 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 213 216 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 217 221 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 221 224 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 400 408 400 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g001">Figure 1</xref>
###xml 1269 1278 1269 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000921.s001">Figure S1</xref>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
###xml 1452 1456 <span type="species:ncbi:10090">mice</span>
###xml 1647 1651 <span type="species:ncbi:10090">mice</span>
To analyze the expression of the integral components of the SMN complex in the spinal cord of severe SMA mice, we isolated spinal cords from normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+;mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3. Total proteins from these tissues were analyzed by Western blot with antibodies against SMN complex components and several SMN-interacting proteins (Figure 1). Similar levels of tubulin and core histones indicate that equal amounts of proteins were present. Compared with normal controls, the levels of Gemin2, Gemin6 and Gemin8 are strongly decreased in the spinal cord of severe SMA mice that express low levels of SMN. Interestingly, Gemin8 is the SMN complex component whose expression is most affected by reduced levels SMN. In contrast, there is little if any reduction in the expression of Gemin4 and unrip proteins, two other integral components of the SMN complex. Although we did not analyze the levels of Gemin3, Gemin5 and Gemin7 for lack of suitable antibodies, decreasing SMN expression in HeLa cells by RNA interference to an extent similar to that in the spinal cord of SMA mice significantly reduces the levels of Gemin2, Gemin6, Gemin7 and Gemin8 but not of Gemin3, Gemin4, Gemin5 or unrip proteins (Figure S1). Interestingly, the levels of several SMN-interacting proteins such as SmB, hnRNP R, hnRNP Q, profilin I and profilin II are not decreased in the spinal cord of severe SMA mice. Collectively, these results demonstrate that reduced levels of SMN markedly affect the expression of a subset of Gemin proteins and in particular of Gemin8 in the spinal cord of severe SMA mice.
###end p 10
###begin title 11
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Expression of SMN complex components in the spinal cord of severe SMA mice.
###end title 11
###begin p 12
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 93 96 93 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 128 131 128 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 229 233 229 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
###xml 282 287 <span type="species:ncbi:10090">mouse</span>
Western blot analysis of equal amounts of total proteins from the spinal cord of normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+;mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3. All mice harbored two copies of human SMN2 gene together with two, one or no copies of the mouse mSmn gene. Proteins were analyzed by SDS/PAGE and Western blot with antibodies against the proteins indicated on the left.
###end p 12
###begin title 13
###xml 63 67 <span type="species:ncbi:10090">mice</span>
SMN levels and snRNP assembly defects in tissues of severe SMA mice
###end title 13
###begin p 14
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Pellizzoni1">[22]</xref>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Matera1">[23]</xref>
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 280 283 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 299 302 299 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 304 308 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 308 311 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 333 336 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 341 344 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 499 508 499 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g002">Figure 2A</xref>
###xml 599 608 599 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g002">Figure 2B</xref>
###xml 947 956 947 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g002">Figure 2C</xref>
###xml 1051 1059 1051 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1220 1224 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Pellizzoni2">[26]</xref>
###xml 1226 1230 1226 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Gabanella1">[42]</xref>
###xml 1412 1428 1412 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g003">Figure 3A and 3B</xref>
###xml 1463 1472 1463 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g002">Figure 2B</xref>
###xml 1589 1598 1589 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g003">Figure 3B</xref>
###xml 1740 1749 1740 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000921.s002">Figure S2</xref>
###xml 2025 2029 2025 2029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Gabanella1">[42]</xref>
###xml 2119 2129 2119 2129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 2139 2143 2139 2143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Rajendra1">[36]</xref>
###xml 2491 2500 2491 2500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g003">Figure 3B</xref>
###xml 2591 2600 2591 2600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g003">Figure 3C</xref>
###xml 2619 2628 2619 2628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g003">Figure 3D</xref>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
###xml 1287 1291 <span type="species:ncbi:10090">mice</span>
###xml 1406 1410 <span type="species:ncbi:10090">mice</span>
###xml 1515 1519 <span type="species:ncbi:10090">mice</span>
###xml 1653 1657 <span type="species:ncbi:10090">mice</span>
###xml 1845 1850 <span type="species:ncbi:10090">mouse</span>
###xml 2226 2230 <span type="species:ncbi:10090">mice</span>
###xml 2736 2740 <span type="species:ncbi:10090">mice</span>
###xml 2762 2766 <span type="species:ncbi:10090">mice</span>
###xml 2841 2845 <span type="species:ncbi:10090">mice</span>
###xml 2867 2871 <span type="species:ncbi:10090">mice</span>
###xml 2980 2984 <span type="species:ncbi:10090">mice</span>
###xml 3042 3046 <span type="species:ncbi:10090">mice</span>
###xml 3214 3218 <span type="species:ncbi:10090">mice</span>
The best-characterized function of the SMN complex is in the assembly of the Sm core on spliceosomal snRNAs [22], [23]. To analyze the effect of reduced SMN expression on snRNP assembly in tissues of SMA mice, we isolated spinal cords, brains and kidneys from normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+; mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3. For each genotype, Western blot analyses show that these tissues contain similar levels of SMN when normalized per cell number (Figure 2A). This pattern is also observed when equal amounts of whole tissue extracts are compared (Figure 2B). To evaluate the extent of SMN decrease, we compared the intensity of SMN signals detected by western blot in serial dilutions of whole spinal cord extracts from normal, carrier and severe SMA mice. SMN levels in spinal cord extracts from carrier and severe SMA mice are, respectively, two-fold and eight-fold lower than in normal mice (Figure 2C). We then analyzed the capacity of equal amounts of these tissue extracts to form Sm cores on in vitro transcribed radioactive U1 snRNA using a well-established ATP-dependent snRNP assembly assay and both gel shift and immunoprecipitation with anti-Sm antibodies [26], [42]. Spinal cord and brain extracts from normal and carrier mice display very efficient snRNP assembly, which is dramatically impaired in the corresponding extracts of severe SMA mice (Figure 3A and 3B). Despite similar amounts of SMN (Figure 2B), kidney extracts from normal and carrier mice show very low Sm core formation compared with extracts from the CNS (Figure 3B) and the reduction in kidney extracts from severe SMA mice is more readily detected upon longer exposure of immunoprecipitation experiments (Figure S2). We have shown previously that snRNP assembly is much more prominent in the CNS than in other mouse tissues during embryogenesis and early postnatal development likely because of changes in the SMN complex activity that occur during development and cellular differentiation [42]. Developmental down-regulation of Sm core formation has been reportedly observed also in Drosophila extracts [36]. Thus, differences in the snRNP assembly activity of distinct tissues from normal mice are consistent with these studies. To quantify the snRNP assembly defect in SMA tissues, the levels of immunoprecipitated U1 snRNA were calculated from four independent experiments in which all tissue extracts were prepared and analyzed at the same time as in Figure 3B to minimize variations. Values are presented following normalization either inter-tissue (Figure 3C) or intra-tissue (Figure 3D). The snRNP assembly activity is decreased ten-fold in both spinal cord and brain extracts from severe SMA mice compared with normal mice (p<0.0001) and approximately four-fold in kidney extracts from severe SMA mice compared with normal mice (p = 0.0438). Interestingly, snRNP assembly is only marginally reduced in spinal cord extracts from carrier mice that have approximately half the amount of SMN of normal mice (p>0.05, not significant). Altogether these results show a similar reduction in SMN levels and a strong impairment of snRNP assembly activity in tissues of severe SMA mice, although the defect appears smaller in kidney than in neural tissue.
###end p 14
###begin title 15
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Analysis of SMN levels in different tissues of severe SMA mice.
###end title 15
###begin p 16
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 93 96 93 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 128 131 128 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 488 492 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 492 495 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 496 500 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 500 503 496 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 515 519 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 519 522 515 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 523 527 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 527 530 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 548 552 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 552 555 548 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 556 560 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 560 563 556 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 899 903 891 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 903 906 895 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 907 911 899 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 911 914 903 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 926 930 918 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 930 933 922 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 934 938 926 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 938 941 930 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 959 963 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 963 966 955 958 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 967 971 959 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 971 974 963 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
(A) Western blot analysis of total proteins from spinal cord, brain or kidney of normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+;mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3. Extracts normalized per cell number (equal amounts of core histones) were analyzed by SDS/PAGE and Western blot with antibodies against the proteins indicated on the left. (B) Western blot analysis of equal amounts of whole tissue extracts (25 microg) from spinal cord, brain or kidney of normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+;mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3. Proteins were analyzed by SDS/PAGE and Western blot with antibodies against SMN and tubulin. (C) Analysis of SMN decrease in the spinal cord of severe SMA mice. Western blot analysis of the indicated serial dilutions (100 equals 50 microg of proteins) of whole tissue extracts from the spinal cord of normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+;mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3. Proteins were analyzed by SDS/PAGE and Western blot with antibodies against SMN and tubulin.
###end p 16
###begin title 17
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> In vitro</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
 In vitro snRNP assembly activity in tissues of severe SMA mice.
###end title 17
###begin p 18
###xml 100 104 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 104 107 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 108 112 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 112 115 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 127 131 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 131 134 127 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 135 139 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 139 142 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 160 164 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 164 167 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 168 172 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 172 175 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 414 422 410 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1192 1195 1186 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1200 1203 1194 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1218 1221 1212 1215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1226 1229 1220 1223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1319 1322 1313 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1327 1330 1321 1324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
###xml 1231 1235 <span type="species:ncbi:10090">mice</span>
###xml 1332 1336 <span type="species:ncbi:10090">mice</span>
(A) Equal amounts of whole tissue extracts (25 microg) from spinal cord, brain or kidney of normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+;mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3 were analyzed in snRNP assembly reactions with radioactive U1 snRNA followed by electrophoresis on native polyacrylamide gels. The position of U1 RNP complexes containing the Sm core is indicated on the left. (B) In vitro snRNP assembly reactions as in (A) were analyzed by immunoprecipitation with anti-Sm (Y12) antibodies followed by electrophoresis on denaturing polyacrylamide gels and autoradiography. (C) Quantification of snRNP assembly activity in whole tissue extracts from normal, carrier and SMA mice. The amount of U1 snRNA immunoprecipitated in snRNP assembly experiments as in (B) was quantified using a STORM 860 Phosphorimager (Molecular Dynamics) and expressed as a percentage of that in brain extracts of normal mice, which is set arbitrarily as 100%. The values from four independent experiments are presented as mean+/-SEM (*p<0.0001, **p<0.05). (D) For each tissue, the amount of U1 snRNA immunoprecipitated in snRNP assembly experiments with extracts from carrier (SMN2+/+;mSmn+/-) and SMA (SMN2+/+;mSmn-/-) mice is expressed as a percentage of that in the corresponding extract from normal (SMN2+/+;mSmn+/+) mice, which is set arbitrarily as 100%.
###end p 18
###begin title 19
###xml 49 53 <span type="species:ncbi:10090">mice</span>
snRNP assembly defects in the spinal cord of SMA mice correlate with disease severity
###end title 19
###begin p 20
###xml 310 319 306 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g004">Figure 4A</xref>
###xml 421 424 417 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 429 432 425 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 448 451 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 456 459 452 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 478 481 474 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 486 489 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 511 514 503 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 524 527 512 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 533 536 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 557 560 545 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 569 572 557 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 578 581 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 611 614 599 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 625 628 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 633 636 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 807 816 791 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g004">Figure 4A</xref>
###xml 184 189 <span type="species:ncbi:10090">mouse</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 801 805 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1009 1013 <span type="species:ncbi:10090">mice</span>
###xml 1221 1225 <span type="species:ncbi:10090">mice</span>
To investigate a potential correlation between impaired snRNP assembly and SMA severity, we analyzed SMN complex expression and snRNP assembly activity in the spinal cord of different mouse models of SMA, including SMNDelta7 SMA mice, mild SMN(A2G) SMA mice and phenotypically rescued high copy SMN2 SMA mice. Figure 4A shows Western blot analysis of SMN complex expression in whole spinal cord extracts from normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+;mSmn+/-), severe SMA (SMN2+/+;mSmn-/-), SMNDelta7 SMA (SMN2+/+;SMNDelta7+/+; mSmn-/-), SMN(A2G) SMA (SMN2+/+;SMN(A2G)+/-; mSmn-/-) and high copy SMN2 SMA (SMN2+/-; SMN2(566)+/-;mSmn-/-) mice at postnatal day 3. The levels of Gemin2, Gemin6 and Gemin8 are strongly decreased in both severe SMA and SMNDelta7 SMA mice compared with normal and carrier mice (Figure 4A). Remarkably, expression of these Gemin proteins is partially restored in the spinal cord of mild SMN(A2G) SMA mice and equivalent to that of controls in the spinal cord of high copy SMN2 SMA mice, which is consistent with the complete rescue of the SMA phenotype. These results highlight a strong correlation between disease severity and decreased expression of Gemin proteins in the spinal cord of SMA mice.
###end p 20
###begin title 21
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> In vitro</italic>
 In vitro snRNP assembly defects correlate with SMA severity.
###end title 21
###begin p 22
###xml 112 116 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 116 119 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 120 124 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 124 127 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 139 143 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 143 146 139 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 147 151 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 151 154 147 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 169 173 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 173 176 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 177 181 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 181 184 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 202 206 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 206 209 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 209 219 201 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;SMN&#916;7</italic>
###xml 219 222 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 223 227 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 227 230 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 247 251 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 251 254 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 254 255 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;</italic>
###xml 263 266 251 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 268 272 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 272 275 260 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 301 305 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 305 308 293 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 309 318 297 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2(566)</italic>
###xml 318 321 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 322 326 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 326 329 314 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 530 538 518 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1237 1246 1219 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2 high</italic>
###xml 1257 1266 1239 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2(566)</italic>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 965 969 <span type="species:ncbi:10090">mice</span>
(A) Western blot analysis of equal amounts of whole tissue extracts (25 microg) from the spinal cord of normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+;mSmn+/-), severe SMA (SMN2+/+;mSmn-/-), SMNDelta7 SMA (SMN2+/+;SMNDelta7+/+;mSmn-/-), SMN(A2G) SMA (SMN2+/+;SMN(A2G)+/- ;mSmn-/-) and high copy SMN2 SMA (SMN2+/-;SMN2(566)+/-;mSmn-/-) mice at postnatal day 3. Proteins were analyzed by SDS/PAGE and Western blot with antibodies against the proteins indicated on the left. (B) Representative snRNP assembly reactions carried out using in vitro transcribed radioactive U1 snRNA and 25 microg of whole spinal cord extracts as in (A) followed by immunoprecipitation with anti-Sm (Y12) antibodies. Immunoprecipitated U1 snRNAs were analyzed by electrophoresis on denaturing polyacrylamide gels and autoradiography. (C) Quantification of snRNP assembly activity in spinal cord extracts from control and SMA mice of different severity. Spinal cord extracts from at least five mice for each of the indicated genotypes were analyzed by snRNP assembly and immunoprecipitation experiments as in (B). The amount of immunoprecipitated U1 snRNA was quantified using a STORM 860 Phosphorimager (Molecular Dynamics). The values are presented as mean+/-SEM. SMN2 high refers to SMN2(566).
###end p 22
###begin p 23
###xml 288 297 288 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g004">Figure 4B</xref>
###xml 512 521 508 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g004">Figure 4C</xref>
###xml 959 963 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 963 966 959 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 967 971 963 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 971 974 967 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
###xml 953 957 <span type="species:ncbi:10090">mice</span>
###xml 1262 1266 <span type="species:ncbi:10090">mice</span>
Next, we investigated snRNP assembly activity in spinal cord extracts from the same mice at postnatal day 3. The efficiency of Sm core formation was analyzed by immunoprecipitation of U1 snRNA from snRNP assembly reactions using anti-Sm antibodies and representative results are shown in Figure 4B. Quantification of U1 levels indicates that there is a ten-fold decrease (p<0.0001) in the snRNP assembly activity of spinal cord extracts from both severe SMA and SMNDelta7 SMA mice compared with normal controls (Figure 4C). Importantly, intermediate levels of snRNP assembly activity are found in SMN(A2G) SMA mice, which are approximately three- to four-fold higher than in severe SMA mice (p<0.05) and two-fold lower than in normal controls (p<0.0001). The snRNP assembly activity in spinal cord extracts from normal, carrier and high copy SMN2 SMA mice is not significantly different (p>0.05). This is particularly interesting in the case of carrier mice (SMN2+/+;mSmn+/-) in which an approximately 50% reduction of SMN levels has very modest if any effects on snRNP assembly activity. Altogether these findings demonstrate that disease severity correlates with the degree of impairment of the SMN complex activity in snRNP assembly in the spinal cord of SMA mice.
###end p 23
###begin title 24
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
snRNP biogenesis is not affected in human fibroblasts from SMA type I patients
###end title 24
###begin p 25
###xml 445 454 445 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g005">Figure 5A</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Wan1">[32]</xref>
###xml 842 849 842 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 917 919 917 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1229 1238 1229 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g005">Figure 5B</xref>
###xml 1483 1487 1483 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Fornerod1">[43]</xref>
###xml 1948 1955 1948 1955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
###xml 516 521 <span type="species:ncbi:9606">human</span>
###xml 1793 1798 <span type="species:ncbi:9606">human</span>
Next, we sought to investigate whether reduced SMN levels and snRNP assembly activity resulted in decreased levels of newly assembled snRNPs in SMA cells. To do so, we used well-characterized human fibroblasts cell lines from type I SMA patients. Western blot analysis shows a reduction in SMN levels ranging from 50% to 75% in four different human SMA fibroblast cell lines compared with control fibroblasts from an healthy carrier individual (Figure 5A). Also, snRNP assembly activity in whole extracts from these human SMA fibroblasts is reduced approximately two- to three-fold (data not shown), which is proportional to the decrease in SMN levels and in agreement with the results of a previous study that analyzed Sm core formation in the same cell lines [32]. To study the consequence of this biochemical deficiency on snRNP synthesis in vivo, control and type I SMA fibroblasts were grown in the presence of [32P] phosphoric acid for six hours to label newly synthesized snRNPs, which were then isolated by immunoprecipitation with anti-Sm antibodies from equal amounts of cell extracts. Surprisingly, we found no significant difference in the levels of snRNPs that are synthesized in control and type I SMA fibroblasts (Figure 5B). Consistent with this, steady-state snRNP levels are also unchanged in these cells (data not shown). Under similar experimental conditions, inihibition of snRNP biogenesis with leptomycin B-a compound that blocks snRNA export from the nucleus [43]-causes a dramatic decrease in the amount of newly synthesized snRNPs indicating that the immunoprecipitation assay is not saturated (data not shown). These results demonstrate that, despite a two- to three-fold reduction in both SMN levels and snRNP assembly activity, snRNP biogenesis is not affected in human type I SMA fibroblasts because fibroblasts contain an excess capacity for Sm core formation relative to their actual requirement for snRNP synthesis in vivo.
###end p 25
###begin title 26
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
SMN levels and in vivo snRNP synthesis in human fibroblasts from type I SMA patients.
###end title 26
###begin p 27
###xml 359 366 355 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 478 485 474 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 500 502 496 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 212 220 <span type="species:ncbi:9606">patients</span>
###xml 424 429 <span type="species:ncbi:9606">human</span>
(A) SMN levels in type I SMA fibroblast cell lines. Western blot analysis of equal amounts of whole cell extracts (25 microg) from human fibroblast cell lines of a normal individual (GM03814) and four type I SMA patients (GM00232, GM09677, GM03813 and GM03815). Proteins were analyzed by SDS/PAGE and Western blot with antibodies against SMN and tubulin. (B) In vivo snRNP synthesis in type I SMA fibroblast cell lines. The human fibroblast cell lines in (A) were pulse-labeled in vivo for 6 h with [32P] phosphoric acid and equal amounts of extracts from these cells (200 microg) were then immunoprecipitated with anti-Sm (Y12) antibodies. The immunoprecipitated snRNAs were analyzed by electrophoresis on denaturing polyacrylamide gels and autoradiography. Known snRNAs are indicated on the left.
###end p 27
###begin title 28
###xml 70 74 <span type="species:ncbi:10090">mice</span>
The levels of a subset of snRNPs are reduced in tissues of severe SMA mice
###end title 28
###begin p 29
###xml 138 145 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 440 443 440 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 448 451 448 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 467 470 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 471 475 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 475 478 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 496 500 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 500 503 500 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 508 511 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 602 604 602 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 754 762 754 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g006">Figure 6</xref>
###xml 1199 1207 1199 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g007">Figure 7</xref>
###xml 1477 1485 1477 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g008">Figure 8</xref>
###xml 2170 2178 2170 2178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g007">Figure 7</xref>
###xml 2438 2445 2438 2445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
###xml 1161 1165 <span type="species:ncbi:10090">mice</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
###xml 1457 1461 <span type="species:ncbi:10090">mice</span>
###xml 1910 1914 <span type="species:ncbi:10090">mice</span>
###xml 2137 2141 <span type="species:ncbi:10090">mice</span>
###xml 2164 2168 <span type="species:ncbi:10090">mice</span>
###xml 2291 2295 <span type="species:ncbi:10090">mice</span>
Monitoring snRNP synthesis in mouse tissues with pulse-labeling experiments such as those described above is not feasible. To address the in vivo consequence of SMN deficiency on snRNP metabolism in the spinal cord of severe SMA mice, we analyzed the steady-state levels of endogenous snRNPs. To do so, we carried out immunoprecipitation experiments with anti-Sm antibodies from equal amounts of whole spinal cord extracts from normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+;mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3. Immunoprecipitated snRNAs were then labeled at the 3'-end with [32P] pCp and analyzed by electrophoresis on denaturing gels and autoradiography, thereby allowing simultaneous assessment of Sm core-containing snRNAs. Figure 6 shows that the levels of at least some snRNPs are decreased in spinal cord extracts from severe SMA mice compared with normal controls. Despite a general trend towards reduction, quantification of snRNA levels from four independent experiments highlights a statistically significant decrease (p<0.05) in the levels of U1, U2, U11 and U12 but not of U4 or U5 snRNAs in the spinal cord of severe SMA mice when compared with carrier mice (Figure 7). Remarkably, U11 is the most severely affected with an average 60% reduction (p = 0.018). These findings were further confirmed by Northern blot analysis of U1 and U11 snRNA levels, which are reduced by 15% and 30% in the spinal cord of severe SMA mice, respectively (Figure 8). Northern blot analysis of total snRNA levels does not distinguish between snRNAs that contain the Sm core and those that do not, and the snRNA decrease is smaller than measured with immunoprecipitation experiments. This observation raises the possibility that a significant fraction of snRNAs is not associated with Sm proteins in SMA tissues. Similar analyses were performed using brain and kidney extracts from the same mice. Interestingly, the consequence of low SMN expression in these tissues differs from the spinal cord because only the levels of U11 and U12 snRNPs in brain and of U11 snRNP in kidney are significantly reduced in severe SMA mice compared with carrier mice (Figure 7). Collectively, these results show that the levels of a subset of snRNPs are reduced in tissues from severe SMA mice, and that defective SMN complex activity in snRNP assembly preferentially affects the accumulation of U11 snRNP of the minor splicing pathway in vivo. Thus, SMN deficiency unevenly changes the snRNP profile of SMA tissues.
###end p 29
###begin title 30
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Analysis of endogenous snRNP levels in the spinal cord of severe SMA mice.
###end title 30
###begin p 31
###xml 84 88 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 88 91 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 92 96 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 96 99 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 111 115 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 115 118 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 120 124 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 124 127 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 145 149 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 149 152 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 153 157 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 157 160 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 300 302 296 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 601 605 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Montzka1">[52]</xref>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
Equal amounts of whole tissue extracts (200 microg) from the spinal cord of normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+; mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3 were immunoprecipitated with anti-Sm (Y12) antibodies. Immunoprecipitated snRNAs were labeled at the 3'-end with [32P] pCp and analyzed by electrophoresis on denaturing polyacrylamide gels and autoradiography. Known snRNAs are indicated on the left. Note that the intensity of signal is not proportional to the abundance of individual snRNAs but reflects the efficiency with which they are labeled by T4 RNA ligase [52].
###end p 31
###begin title 32
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Quantification of endogenous snRNP levels in tissues of severe SMA mice.
###end title 32
###begin p 33
###xml 163 167 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 167 170 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 171 175 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 175 178 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 190 194 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 194 197 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 198 202 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 202 205 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 223 227 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 227 230 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 231 235 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 235 238 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 287 295 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g006">Figure 6</xref>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
Immunoprecipitation experiments with anti-Sm (Y12) antibodies from whole tissue extracts (200 microg) from either spinal cord, brain or kidney extracts of normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+;mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3 were carried out as in Figure 6. The relative amount of individual snRNAs immunoprecipitated from each tissue was quantified using a STORM 860 Phosphorimager (Molecular Dynamics) and expressed as a percentage of that in normal mice, which is set arbitrarily as 100%. The values from four independent experiments are presented as mean+/-SEM (*p<0.05). Normal (black bars); carrier (dark grey bars); severe SMA (light grey bars).
###end p 33
###begin title 34
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Analysis of endogenous U1 and U11 snRNA levels in the spinal cord of severe SMA mice.
###end title 34
###begin p 35
###xml 147 151 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 151 154 147 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 155 159 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 159 162 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 189 192 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 185 192 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2<sup>+/+</sup></italic>
###xml 197 200 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 193 200 189 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn<sup>&#8722;/&#8722;</sup></italic>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
(A) Northern blot analysis of four increasing concentrations (0.5, 1, 2 and 4 microg) of total RNA from whole spinal cord extracts of five normal (SMN2+/+;mSmn+/+) and five severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3 with probes specific for the RNAs indicated on the left. (B) The intensity of signal of individual RNAs at each concentration was quantified using a STORM 860 Phosphorimager (Molecular Dynamics) and values in the severe SMA mice were expressed as a percentage of the corresponding ones in normal mice, which are set arbitrarily as 100%. The values are presented as mean+/-SEM. Normal (black bars); severe SMA (light grey bars).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Meister1">[20]</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Matera1">[23]</xref>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Jurica1">[44]</xref>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
###xml 781 786 <span type="species:ncbi:10090">mouse</span>
Despite steady progress in our understanding of the genetic basis of SMA, the molecular functions of SMN and the development of animal models, the defect responsible for the specific degeneration of motor neurons in the spinal cord of SMA patients remains elusive. The best-characterized activity of the SMN complex is the assembly of Sm proteins onto snRNAs forming the spliceosomal snRNPs [20]-[23]. These abundant nuclear RNPs function in the context of a dynamic macromolecular machine known as the spliceosome to carry out the excision of introns and ligation of exons to form mature mRNAs [44]. With the goal of understanding SMA pathophysiology, here we have characterized SMN complex activity and the consequence of its deficiency on snRNP metabolism in the spinal cord of mouse models of the disease.
###end p 37
###begin p 38
###xml 309 318 309 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g001">Figures 1</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000921.s001">S1</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Carissimi1">[27]</xref>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Feng1">[29]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Shpargel1">[31]</xref>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Helmken1">[45]</xref>
###xml 801 810 801 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g004">Figure 4A</xref>
###xml 1137 1141 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Avila1">[46]</xref>
###xml 1246 1250 1242 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Carissimi1">[27]</xref>
###xml 1251 1255 1247 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Shpargel1">[31]</xref>
###xml 1494 1502 1490 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g003">Figure 3</xref>
###xml 1653 1662 1649 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g002">Figures 2</xref>
###xml 1667 1668 1663 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g003">3</xref>
###xml 2089 2105 2085 2101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g004">Figure 4B and 4C</xref>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 1060 1064 <span type="species:ncbi:10090">mice</span>
###xml 1365 1369 <span type="species:ncbi:10090">mice</span>
###xml 1488 1492 <span type="species:ncbi:10090">mice</span>
###xml 1950 1954 <span type="species:ncbi:10090">mice</span>
###xml 2050 2054 <span type="species:ncbi:10090">mice</span>
We demonstrated that the levels of a subset of Gemin proteins (namely Gemin2, Gemin6 and Gemin8) are significantly reduced in the spinal cord of severe SMA mice compared with normal mice, and that Gemin8 is an integral component of the SMN complex whose expression is most severely affected by decreased SMN (Figures 1 and S1). In contrast, the levels of Gemin4 and unrip as well as those of several other SMN-interacting proteins are unchanged. The SMN-dependent reduction of Gemin proteins expression has also been observed in cultured cell lines and likely results from degradation due to defective incorporation into SMN complexes [27], [29], [31], [45]. Importantly, the degree of reduction in Gemin2, Gemin6 and Gemin8 expression in the spinal cord of SMA mice correlates with disease severity (Figure 4A), suggesting that these proteins might be involved in the cellular activities of SMN whose impairment underlies SMA pathology. In this regard, it is noteworthy that the beneficial effect of treatment with trichostatin A on survival of SMNDelta7 SMA mice correlates with increased levels of functional SMN complexes in the CNS [46]. Decreased levels of Gemin2, Gemin6 and Gemin8-which are required for efficient snRNP assembly activity [27]-[31]-may also exacerbate the consequence of reduced SMN expression on Sm core formation in the spinal cord of SMA mice. Indeed, we demonstrated that snRNP assembly activity is dramatically reduced in spinal cord extracts from severe SMA mice (Figure 3). A similar decrease in SMN levels and severe impairment of Sm core formation are also observed in extracts from the other SMA tissues analyzed here (Figures 2 and 3). Although quantitative differences exist in the snRNP assembly activity of distinct normal tissues and possibly also in the extent of its decrease in SMA tissues, these results indicate that reduced capacity for Sm core formation is a general biochemical deficiency in severe SMA mice. Importantly, we showed that the degree of snRNP assembly impairment in the spinal cord of SMA mice correlates with disease severity (Figure 4B and 4C). Collectively, our findings provide strong support to the possibility that deficiencies in snRNP biogenesis contribute to SMA pathology.
###end p 38
###begin p 39
###xml 230 239 230 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g006">Figures 6</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g007">7</xref>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g008">8</xref>
###xml 354 362 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g001">Figure 1</xref>
###xml 704 714 704 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Wan1">[32]</xref>
###xml 757 761 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Rajendra1">[36]</xref>
###xml 955 963 955 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1200 1208 1200 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1307 1314 1307 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1398 1405 1398 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1687 1694 1687 1694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2019 2026 2019 2026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2070 2078 2070 2078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000921-g005">Figure 5</xref>
###xml 2271 2278 2271 2278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2512 2516 2512 2516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Rajendra1">[36]</xref>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 2595 2600 <span type="species:ncbi:10090">mouse</span>
###xml 2790 2794 <span type="species:ncbi:10090">mice</span>
For the first time, we demonstrated here that the impairment of SMN function in Sm core formation leads to a significant decrease in the levels of a subset of snRNPs in the spinal cord as well as other tissues of severe SMA mice (Figures 6, 7 and 8). As indicated also by similar levels of SmB protein in the spinal cord of normal, carrier and SMA mice (Figure 1), the bulk of snRNPs is however only marginally affected in SMA tissues. This is especially remarkable considering the ten-fold decrease in snRNP assembly activity in neural tissues from SMA mice. It is also in agreement with the observation that steady-state snRNP levels are unchanged in DT40 cells with severely reduced SMN levels and in Drosophila larvae harboring SMN null mutations [32], [36]. In light of the striking discrepancy between the degree of reduction in snRNP assembly and snRNP levels in tissues of SMA mice as well as other model systems, it is important to consider that in vitro snRNP assembly assays measure the capacity of Sm core formation in extracts, which likely corresponds to the amount of SMN complexes bound to Sm proteins and therefore capable of snRNP assembly. However, reduced snRNP assembly capacity in vitro as a consequence of low SMN levels may not necessarily translate into a defect of snRNP synthesis in vivo if the SMN complexes are in excess. In order for snRNP accumulation to be affected in vivo, the SMN complex must fail to meet the demand for Sm core formation on the snRNAs, which is dictated primarily by the rate of snRNA transcription. Thus, the physiologically critical parameter is the threshold of SMN activity required to support the level of snRNP synthesis needed in vivo, which likely differs in distinct cells and changes also with development. Only if SMN activity decreases below this threshold insufficient snRNPs are made and steady-state snRNP levels may be affected. Although it is generally assumed that snRNP assembly is rate limiting in SMA, we found surprisingly that snRNP synthesis in vivo is not affected in type I SMA fibroblasts (Figure 5). Together with the overall modest reduction of snRNP levels in SMA tissues, these results suggest that SMN complexes competent for snRNP assembly greatly exceed the amount needed to meet the in vivo demand for snRNP synthesis in most tissues and that decreased SMN levels have little if any impact on snRNP accumulation in SMA. An important implication is that, somewhat similar to the situation in larval lethal Drosophila mutants [36], the specific neuromuscular phenotype triggered by systemic SMN deficiency in mouse models of SMA is not caused by global depletion of spliceosomal snRNPs. Nevertheless, our finding that the levels of a subset of snRNPs are significantly decreased in tissues of severe SMA mice indicates that there are at least some cells in SMA in which SMN capacity for snRNP assembly becomes overwhelmed and insufficient snRNPs are made possibly due to a requirement for high levels of snRNP synthesis.
###end p 39
###begin p 40
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Patel1">[47]</xref>
###xml 781 785 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Patel1">[47]</xref>
###xml 787 791 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Wu1">[48]</xref>
###xml 944 948 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Alioto1">[49]</xref>
###xml 949 953 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Sheth1">[51]</xref>
###xml 1039 1040 1039 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1043 1044 1043 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1118 1119 1118 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1122 1123 1122 1123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1134 1138 1134 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Montzka1">[52]</xref>
###xml 1218 1222 1218 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Pellizzoni2">[26]</xref>
###xml 1224 1228 1224 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Yong1">[53]</xref>
###xml 2206 2210 2206 2210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Levine1">[50]</xref>
###xml 2212 2216 2212 2216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Patel2">[54]</xref>
###xml 931 936 <span type="species:ncbi:9606">human</span>
###xml 1661 1665 <span type="species:ncbi:10090">mice</span>
###xml 2403 2411 <span type="species:ncbi:9606">patients</span>
One of the most strikingly unexpected findings of our study is that impairment of SMN ubiquitous function specifically alters the snRNP profile of SMA tissues by decreasing the levels of a subset of snRNPs and more prominently of U11. Spliceosomal snRNPs are divided into two distinct classes depending on the type of introns that they remove [47]. The vast majority of eukaryotic introns are processed by the major (or U2-dependent) spliceosome formed by U1, U2, U4/U6 and U5 snRNPs. Less than 1% of introns are processed by the minor (or U12-dependent) spliceosome comprising U11, U12, U4atac/U6atac and U5 snRNPs. Specific conserved sequence features distinguish the two types of introns and determine their commitment to either the major or the minor pre-mRNA splicing pathway [47], [48]. Bioinformatic analysis of intron sequences from the databases reveals the presence of approximately seven hundred U12-type introns in the human genome [49]-[51]. Consistent with the relatively low abundance of the target introns, minor snRNAs (103-104 per cell) are two orders of magnitude less abundant than major snRNAs (105-106 per cell) [52]. Although the SMN complex assembles the Sm core on both major and minor snRNAs [26], [53], differences in the abundance, efficiency of Sm core formation and turnover rate of individual snRNAs might contribute to the observed effects of SMN deficiency on the levels of specific snRNPs. Future studies will be needed to address these issues directly. Regardless of the mechanism(s), however, our results indicate that SMN deficiency unevenly alters the physiological proportion of endogenous snRNPs in tissues of severe SMA mice, and preferentially affects the accumulation of U11 snRNP of the minor splicing pathway. These findings have important potential implications for SMA pathogenesis because the disease trigger targeted by SMN reduction may lie within genes containing introns processed by the minor splicing pathway. There is evidence that processing of U12-type introns is slower and possibly more error prone than that of U2-type introns under normal conditions and might represent a rate-limiting step in the expression of genes that contain these introns [50], [54]. Decreased levels of minor snRNPs such as U11 may further enhance this situation and have deleterious consequences on the expression of mRNAs containing U12-type introns in cells of SMA patients. It is also conceivable that although the minor splicing pathway processes a number of genes only a few may be affected by SMN reduction because of differences in the splicing efficiency of individual U12-type introns.
###end p 40
###begin p 41
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Faustino1">[55]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Licatalosi1">[56]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-KuyumcuMartinez1">[57]</xref>
###xml 892 896 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Lueck1">[58]</xref>
###xml 1044 1048 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Lueck2">[59]</xref>
###xml 1414 1418 1414 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Wu1">[48]</xref>
###xml 1419 1423 1419 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Sheth1">[51]</xref>
###xml 1602 1606 1602 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Wu1">[48]</xref>
###xml 1882 1886 1882 1886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Flink1">[60]</xref>
###xml 1887 1891 1887 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Vincent1">[62]</xref>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 670 675 <span type="species:ncbi:10090">mouse</span>
###xml 1866 1871 <span type="species:ncbi:9606">human</span>
Dysfunctions in components of both constitutive and regulated pre-mRNA splicing have been implicated in the disease mechanisms of an increasing number of human disorders [55], [56]. In addition, there is precedent for a model where reduction of a particular splicing factor results in a tissue-specific phenotype. Myotonic dystrophy is caused by nucleotide repeat expansions in the non-coding region of specific mRNAs, which act to sequester splicing factors such as the muscle blind protein away from the pre-mRNA processing machinery leading to aberrant processing of distinct target mRNAs in different tissues [57]. As a consequence of this splicing deregulation, in mouse models of myotonic dystrophy, the chloride channel 1 gene is processed incorrectly during early postnatal development of skeletal muscle and the fetal mRNA form that is not active in chloride conductance is retained [58]. In turn, this affects the physiological increase in chloride channel conductance in skeletal muscle resulting in myotonia and muscle degeneration [59]. It is tantalizing to speculate that the processing of one or more introns in specific genes that have a critical role in motor neuron biology might be similarly affected by reduced functionality of the U12-dependent spliceosome in SMA. It is noteworthy that U12-dependent introns are not randomly distributed in the genome but rather enriched in few gene families [48]-[51]. Members of the voltage-gated ion channel gene family contain an unusually high frequency of U12-dependent introns and are especially interesting in the context of SMA pathology [48]. These genes control numerous activities that are critical for neuronal function and muscle contraction, including action potential, signaling processes and synaptic transmission, and whose deficiency is responsible for several neuromuscular and neurological human disorders [60]-[62]. One attractive albeit presently speculative scenario is that altered processing of some members of this gene family could cause electrophysiological disturbances that contribute to motor unit dysfunction and SMA pathophysiology. It should be pointed out however that there is no evidence of splicing defects in SMA and it is not known whether the reduction of snRNP levels reported here would indeed affect the functionality of the minor pre-mRNA splicing pathway. Future studies will be needed to address the many questions stemming from our work. In particular, whether the minor splicing pathway rather than the major splicing pathway is affected in SMA and whether defective processing of specific mRNAs containing U12-dependent introns contributes to the preferential vulnerability of motor neurons to reduced levels of SMN.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
Animals and tissue harvesting
###end title 43
###begin p 44
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 79 82 79 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 67 82 67 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2<sup>+/+</sup>;mSmn<sup>+/&#8722;</sup></italic>
###xml 119 125 119 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Msd</sup>
###xml 93 125 93 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FVB.Cg-Tg(SMN2)89Ahmb Smn1<sup>tm1Msd</sup></italic>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani3">[16]</xref>
###xml 210 213 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 223 226 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 231 234 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 206 234 202 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2<sup>+/+</sup>;Smn&#916;7<sup>+/+</sup>;mSmn<sup>+/&#8722;</sup></italic>
###xml 297 303 289 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Msd</sup>
###xml 247 303 239 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FVB.Cg-Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb Smn1<sup>tm1Msd</sup></italic>
###xml 305 309 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Le1">[18]</xref>
###xml 372 375 364 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 384 387 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 392 395 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 368 395 360 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2<sup>+/+</sup>;SMN(A2G)<sup>+/+</sup>;mSmn<sup>+/&#8722;</sup></italic>
###xml 455 461 447 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Msd</sup>
###xml 408 461 400 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FVB.Cg-Tg(SMN1*A2G)2023Ahmb Tg(SMN2)89Ahmb Smn1<sup>tm1Msd</sup></italic>
###xml 497 500 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 505 508 497 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 493 508 485 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2<sup>+/+</sup>;mSmn<sup>+/&#8722;</sup></italic>
###xml 508 512 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani4">[19]</xref>
###xml 592 595 584 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 605 608 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 613 616 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 584 616 576 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2(89)<sup>+/+</sup>;SMN2(566)<sup>+/+</sup>;mSmn<sup>+/&#8722;</sup></italic>
###xml 650 653 642 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 646 653 638 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn<sup>+/&#8722;</sup></italic>
###xml 653 657 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani3">[16]</xref>
###xml 770 807 762 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Guide for the Care and Use of Animals</italic>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 911 916 <span type="species:ncbi:10090">Mouse</span>
Severe SMA mice were produced from carrier parents of the genotype SMN2+/+;mSmn+/- (line 89; FVB.Cg-Tg(SMN2)89Ahmb Smn1tm1Msd) [16]. SMNDelta7 SMA mice were generated from males and females of the genotype SMN2+/+;SmnDelta7+/+;mSmn+/- (line 4299; FVB.Cg-Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb Smn1tm1Msd) [18]. SMN(A2G) SMA mice were bred from males with the genotype SMN2+/+;SMN(A2G)+/+;mSmn+/- (line 2023; FVB.Cg-Tg(SMN1*A2G)2023Ahmb Tg(SMN2)89Ahmb Smn1tm1Msd) and females with the genotype SMN2+/+;mSmn+/-[19]. High copy SMN2 SMA mice were produced by mating males of the genotype SMN2(89)+/+;SMN2(566)+/+;mSmn+/- with females of the genotype mSmn+/-[16]. All experiments were conducted in accordance with the protocols described in the National Institutes of Health Guide for the Care and Use of Animals and were approved by the Ohio State University Institutional Laboratory Animal Care and Use Committee. Mouse tissues were harvested from neonatal pups at postnatal day 3 (with birth being defined as postnatal day 1). The pups were lightly anesthetized with isoflurane and were then euthanized by rapid decapitation. Forebrains, spinal cords and kidneys were rapidly dissected and immediately frozen in liquid nitrogen. All tissue samples were stored at -80degreesC until use. A tail biopsy, which was used for genotyping, was also taken from each pup.
###end p 44
###begin title 45
Genotyping
###end title 45
###begin p 46
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani3">[16]</xref>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Monani4">[19]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Butchbach2">[63]</xref>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 554 558 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn</italic>
###xml 892 895 832 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 888 895 828 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn<sup>&#8722;/&#8722;</sup></italic>
###xml 1020 1023 960 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1016 1023 956 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn<sup>+/&#8722;</sup></italic>
###xml 1118 1121 1058 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1114 1121 1054 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSmn<sup>+/+</sup></italic>
###xml 1573 1577 1479 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 1927 1931 1803 1807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 1947 1951 1823 1827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 2224 2228 2100 2104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Alexander1">[64]</xref>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1010 1014 <span type="species:ncbi:10090">mice</span>
###xml 1108 1112 <span type="species:ncbi:10090">mice</span>
Neonatal offspring were genotyped using a PCR-based assay on genomic DNA from tail biopsies-obtained after death-as described previously [16]-[19], [63]. The presence of the mSmn knockout allele was determined by PCR amplification of NeoR/mSmn junction site: NeoB, 5'-gcagctgtgctcgacgttgtc-3' and SmnInt2R, 5'-taagaaagcctcgacgttgtc-3' (PCR conditions: 95degreesC for 4 min, 35 cycles of 95degreesC for 1 min, 63degreesC for 1.5 min and 72degreesC for 1 min followed by a final extension at 72degreesC for 4 min). PCR primers designed to detect an intact mSmn allele were used to distinguish SMA pups from carrier pups: mSmnEx2AF, 5'-ttttctccctcttcagagtgat-3' and mSmnEx2BR, 5'-ctgtttcaagggagttgtggc-3' (PCR conditions: 95degreesC for 4 min, 32 cycles of 95degreesC for 1 min, 57degreesC for 1 min and 72degreesC for 1 min followed by a final extension at 72degreesC for 4 min). SMA mice (mSmn-/-) would be positive for the mSmn knockout PCR reaction and negative for the intact mSmn PCR reaction while carrier mice (mSmn+/-) would be positive for both the mSmn knockout and intact mSmn PCR reactions. Normal mice (mSmn+/+) would test negative for the mSmn knockout PCR but positive for the intact mSmn PCR reaction. Both the SMN(A2G) and SMNDelta7 transgenes were identified by using the following PCR primers: SMNex4.5F, 5'-actgggaccaggaaagccaggt-3' and SMNex6R, 5'-gccagtatgatagccactcatg-3' (PCR conditions: 95degreesC for 4 min, 32 cycles of 95degreesC for 1 min, 57degreesC for 1 min and 72degreesC for 1 min followed by a final extension at 72degreesC for 4 min). The SMN2 transgene (both lines 89 and 566) was detected by the following PCR reaction: SMN2F2, 5'-gcgatagagtgagactccatct-3' and SMN2R1, 5'-gacatagaggtctgatctttagct-3' (PCR conditions: 95degreesC for 4 min, 32 cycles of 95degreesC for 1 min, 57degreesC for 1 min and 72degreesC for 1 min followed by a final extension at 72degreesC for 4 min). To distinguish SMN2 (line 89) from SMN2 (line 566), we performed the above PCR using a limited number of 20 cycles and normalized band intensity to that obtained from PCR-based detection of the endogenous, single-copy gene, IL-2 (IL2-F, 5'-ctaggccacagaattgaaagatct-3' and IL2-R, 5'-gtaggtggaaattctagcatcatcc-3') [64].
###end p 46
###begin title 47
Antibodies
###end title 47
###begin p 48
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Liu1">[65]</xref>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Charroux1">[66]</xref>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Carissimi2">[28]</xref>
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Carissimi1">[27]</xref>
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Carissimi1">[27]</xref>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Mourelatos1">[67]</xref>
The antibodies used in this study were as follows: anti-SMN clone 8 (BD Transduction Laboratories), anti-Gemin2 2E17 [65], anti-Gemin4 17D10 [66], anti-Gemin6 20H8 [28], anti-Gemin8 1F8 [27], anti-unrip 3G6 [27], anti-Sm Y12 (Lab Vision), anti-hnRNP R/Qs 18E4 [67], anti-H1 and core histones (Chemicon), anti-tubulin DM 1A (Sigma), anti-Profilin I and anti-Profilin II (kindly provided by Dr. Witke).
###end p 48
###begin title 49
Cell culture and treatments
###end title 49
###begin p 50
###xml 324 331 324 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 408 410 404 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
###xml 206 212 <span type="species:ncbi:9913">bovine</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
Human fibroblast cell lines from one normal carrier individual (GM03814) and four type I SMA patients (GM00232, GM09677, GM03813, GM03815) were grown in RPMI 1640 medium (BioWhittaker) containing 15% fetal bovine serum, 2 mM glutamine and 1% penicillin/streptomycin. In pulse-labeling experiments to monitor snRNP synthesis in vivo, subconfluent human fibroblasts were incubated for 6 h with 100 microCi of [32P] phosphoric acid in medium without phosphate.
###end p 50
###begin title 51
Extract preparation
###end title 51
###begin p 52
###xml 329 330 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Gabanella1">[42]</xref>
Total protein extracts for Western blot analyses were prepared by homogenization of frozen tissues in SDS/PAGE sample buffer followed by brief sonication and boiling. Whole cell and tissue extracts were prepared by homogenization of frozen tissues with ice-cold reconstitution buffer (20 mM Hepes-KOH pH 7.9, 50 mM KCl, 5 mM MgCl2, 0.2 mM EDTA, 5% glycerol) containing 0.01% NP40 as previously described [42]. Homogenates were then passed five times through a 25G needle and centrifuged 15 min at 10,000 rpm at 4degreesC. Supernatants were collected and protein concentration measured using the Lowry method (Biorad). Extracts were then used directly for snRNP assembly experiments or stored in frozen aliquots at -80degreesC for Western blot and immunoprecipitation experiments. All protein analyses were carried out by SDS/PAGE on 12% polyacrylamide gels and Western blot.
###end p 52
###begin title 53
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro assembly of snRNPs
###end title 53
###begin p 54
###xml 90 92 86 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 464 466 442 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 528 532 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Pellizzoni2">[26]</xref>
###xml 534 538 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Gabanella1">[42]</xref>
###xml 516 522 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
U1 snRNA was transcribed in vitro from a linearized template DNA in the presence of [alpha32P] UTP (3000 Ci/mmol) and m7G cap analogue (New England Biolabs), and then purified from denaturing polyacrylamide gels according to standard procedures. The snRNP assembly reactions were carried out for 1 h at 30degreesC in a volume of 20 microl of reconstitution buffer containing 0.01% NP40, 25 microg of whole tissue extracts, 10,000 cpm of in vitro transcribed [alpha32P] UTP-labeled U1 snRNA, 2.5 mM ATP and 10 microM E.coli tRNA [26], [42]. Reactions were then analyzed by immunoprecipitation with anti-Sm (Y12) antibodies or, following addition of heparin and urea to a final concentration of 5 mg/ml and 2 M, respectively, by electrophoresis on 6% polyacrylamide native gels at 4degreesC and autoradiography.
###end p 54
###begin title 55
Immunoprecipitation experiments
###end title 55
###begin p 56
###xml 202 203 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 321 322 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 324 325 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 587 589 577 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Immunoprecipitations with anti-Sm (Y12) antibodies from snRNP assembly reactions or whole tissue extracts (200 microg) were carried out in RSB-500 buffer (500 mM NaCl, 10 mM Tris-HCl pH 7.4, 2.5 mM MgCl2) containing 0.1% NP40, EDTA-free protease inhibitor cocktail (Roche) and phosphatase inhibitors (50 mM NaF, 0.2 mM Na3VO4) for 2 h at 4degreesC. After five washes with the same buffer, bound RNAs were recovered from immunoprecipitates by proteinase K treatment, phenol/chloroform extraction and ethanol precipitation. 3'-end labeling experiments were carried out in the presence of [32P] pCp (3000Ci/mmol) and T4 RNA ligase (Roche) following manufacturer's instructions, and unincorporated nucleotides were removed by centrifugation through micro Bio-Spin P-30 columns (Biorad). RNAs were analyzed by electrophoresis on 6% polyacrylamide/8M urea gels and autoradiography. Immunoprecipitated snRNAs were quantified using a STORM 860 Phosphorimager (Molecular Dynamics) and the ImageQuant version 4.2 software. Two-tailed P values were calculated using the unpaired Student t test and the InStat software.
###end p 56
###begin title 57
Northern blot analysis
###end title 57
###begin p 58
###xml 444 452 444 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 478 480 474 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 564 565 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 245 250 <span type="species:ncbi:10090">mouse</span>
###xml 284 289 <span type="species:ncbi:10090">mouse</span>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
###xml 381 386 <span type="species:ncbi:10090">mouse</span>
Total RNA from whole spinal cord extracts was analyzed by electrophoresis on 6% polyacrylamide/8M urea gel or 1% agarose-formaldehyde gel and transferred to a nylon membrane (Genescreen Plus, Perkin Elmer). Antisense RNA probes corresponding to mouse U1 (from nucleotide 122 to 157), mouse U11 (from nucleotide 58 to 82), mouse 28S ribosomal RNA (from nucleotide 4400 to 4515) and mouse GAPDH mRNA (from nucleotide 345 to 660) were transcribed in vitro in the presence of [alpha32P] UTP (3000 Ci/mmol) using the MEGAshortscript T7 kit (Ambion). RNA probes (0,75x106 cpm/ml) and sheared salmon sperm DNA (200 microg/ml) were denatured at 100degreesC for 5 min and then transferred to ice. Hybridization was carried out overnight at 50degreesC in hybridization buffer (1 M NaCl, 10% dextran sulphate, 50% formamide, 1% SDS).
###end p 58
###begin title 59
Supporting Information
###end title 59
###begin p 60
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Carissimi1">[27]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000921-Feng1">[29]</xref>
SMN knockdown affects the levels of a subset of Gemin proteins in HeLa cells. (A) HeLa S3 cells were transfected with siRNAs against SMN, Gemin8 and luciferase (control) that have been previously described [27]-[29]. 72 hours post-transfection, equal amounts of total proteins were analyzed by Western blot with antibodies against the proteins indicated on the left. SMN knockdown in HeLa cells markedly affects the levels of Gemin2, Gemin6, Gemin7 and Gemin8 but not of Gemin3, Gemin4, Gemin5 and unrip. Note that Gemin2 decrease is not observed upon Gemin8 knockdown and thus specific for SMN reduction. (B) To quantify the decrease of Gemin proteins that are affected by SMN knockdown, total proteins from HeLa cells in which Gemin8 and SMN levels were reduced by RNA interference as in (A) were analyzed together with the indicated serial dilutions of total proteins from HeLa cells treated with siRNAs against luciferase (control). Proteins were analyzed by Western blot with antibodies against the proteins indicated on the left. For each Gemin protein, direct comparison of signal intensity detected by western blot in the SMN RNAi sample and in serial dilutions of the control RNAi sample indicates that SMN decrease most prominently affects the levels of Gemin8 followed by Gemin2, Gemin6 and Gemin7.
###end p 60
###begin p 61
(0.90 MB TIF)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
In vitro snRNP assembly activity in kidney of severe SMA mice. Equal amounts of whole tissue extracts (25 mug) from the kidney of normal (SMN2+/+;mSmn+/+), carrier (SMN2+/+; mSmn+/-) and severe SMA (SMN2+/+;mSmn-/-) mice at postnatal day 3 were analyzed in snRNP assembly reactions with radioactive U1 snRNA followed by immunoprecipitation with anti-Sm (Y12) antibodies. Input (2.5%) and immunoprecipitated U1 snRNAs were analyzed by electrophoresis on denaturing polyacrylamide gels and autoradiography.
###end p 63
###begin p 64
(0.14 MB TIF)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
We are grateful to Gideon Dreyfuss and Walter Witke for the kind gift of antibodies.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
The neurobiology of childhood spinal muscular atrophy.
###end article-title 68
###begin article-title 69
The molecular bases of spinal muscular atrophy.
###end article-title 69
###begin article-title 70
Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.
###end article-title 70
###begin article-title 71
Molecular mechanisms in spinal muscular atrophy: models and perspectives.
###end article-title 71
###begin article-title 72
Therapeutics development for spinal muscular atrophy.
###end article-title 72
###begin article-title 73
Identification and characterization of a spinal muscular atrophy-determining gene.
###end article-title 73
###begin article-title 74
A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.
###end article-title 74
###begin article-title 75
A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.
###end article-title 75
###begin article-title 76
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN.
###end article-title 76
###begin article-title 77
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.
###end article-title 77
###begin article-title 78
The survival motor neuron protein in spinal muscular atrophy.
###end article-title 78
###begin article-title 79
Correlation between severity and SMN protein level in spinal muscular atrophy.
###end article-title 79
###begin article-title 80
Perspectives on models of spinal muscular atrophy for drug discovery.
###end article-title 80
###begin article-title 81
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy.
###end article-title 81
###begin article-title 82
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model for spinal muscular atrophy.
###end article-title 82
###begin article-title 83
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.
###end article-title 83
###begin article-title 84
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.
###end article-title 84
###begin article-title 85
###xml 103 107 <span type="species:ncbi:10090">mice</span>
SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.
###end article-title 85
###begin article-title 86
###xml 95 99 <span type="species:ncbi:10090">mice</span>
A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.
###end article-title 86
###begin article-title 87
SMN-mediated assembly of RNPs: a complex story.
###end article-title 87
###begin article-title 88
The SMN complex, an assemblyosome of ribonucleoproteins.
###end article-title 88
###begin article-title 89
Chaperoning ribonucleoprotein biogenesis in health and disease.
###end article-title 89
###begin article-title 90
Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs.
###end article-title 90
###begin article-title 91
The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis.
###end article-title 91
###begin article-title 92
A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs.
###end article-title 92
###begin article-title 93
Essential role for the SMN complex in the specificity of snRNP assembly.
###end article-title 93
###begin article-title 94
Gemin8 is a novel component of the survival motor neuron complex and functions in small nuclear ribonucleoprotein assembly.
###end article-title 94
###begin article-title 95
Gemin8 is required for the architecture and function of the survival motor neuron complex.
###end article-title 95
###begin article-title 96
Gemins modulate the expression and activity of the SMN complex.
###end article-title 96
###begin article-title 97
Gemin2 plays an important role in stabilizing the survival of motor neuron complex.
###end article-title 97
###begin article-title 98
Gemin proteins are required for efficient assembly of Sm-class ribonucleoproteins.
###end article-title 98
###begin article-title 99
The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy.
###end article-title 99
###begin article-title 100
Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy.
###end article-title 100
###begin article-title 101
Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis.
###end article-title 101
###begin article-title 102
###xml 56 65 <span type="species:ncbi:7955">zebrafish</span>
Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding.
###end article-title 102
###begin article-title 103
###xml 2 25 <span type="species:ncbi:7227">Drosophila melanogaster</span>
A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle.
###end article-title 103
###begin article-title 104
Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons.
###end article-title 104
###begin article-title 105
Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons.
###end article-title 105
###begin article-title 106
Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization.
###end article-title 106
###begin article-title 107
Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy.
###end article-title 107
###begin article-title 108
###xml 39 47 <span type="species:ncbi:9606">patients</span>
SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins.
###end article-title 108
###begin article-title 109
The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation.
###end article-title 109
###begin article-title 110
CRM1 is an export receptor for leucine-rich nuclear export signals.
###end article-title 110
###begin article-title 111
Pre-mRNA splicing: awash in a sea of proteins.
###end article-title 111
###begin article-title 112
Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1.
###end article-title 112
###begin article-title 113
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy.
###end article-title 113
###begin article-title 114
Splicing double: insights from the second spliceosome.
###end article-title 114
###begin article-title 115
AT-AC pre-mRNA splicing mechanisms and conservation of minor introns in voltage-gated ion channel genes.
###end article-title 115
###begin article-title 116
U12DB: a database of orthologous U12-type spliceosomal introns.
###end article-title 116
###begin article-title 117
###xml 54 59 <span type="species:ncbi:9606">human</span>
A computational scan for U12-dependent introns in the human genome sequence.
###end article-title 117
###begin article-title 118
Comprehensive splice-site analysis using comparative genomics.
###end article-title 118
###begin article-title 119
###xml 25 30 <span type="species:ncbi:9606">human</span>
Additional low-abundance human small nuclear ribonucleoproteins: U11, U12, etc.
###end article-title 119
###begin article-title 120
snRNAs contain specific SMN-binding domains that are essential for snRNP assembly.
###end article-title 120
###begin article-title 121
The splicing of U12-type introns can be a rate-limiting step in gene expression.
###end article-title 121
###begin article-title 122
###xml 22 27 <span type="species:ncbi:9606">human</span>
Pre-mRNA splicing and human disease.
###end article-title 122
###begin article-title 123
Splicing regulation in neurologic disease.
###end article-title 123
###begin article-title 124
Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.
###end article-title 124
###begin article-title 125
Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1.
###end article-title 125
###begin article-title 126
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy.
###end article-title 126
###begin article-title 127
Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
###end article-title 127
###begin article-title 128
Inherited disorders of voltage-gated sodium channels.
###end article-title 128
###begin article-title 129
Autoimmune channelopathies and related neurological disorders.
###end article-title 129
###begin article-title 130
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
A novel method for oral delivery of drug compounds to the neonatal SMNDelta7 mouse model of spinal muscular atrophy.
###end article-title 130
###begin article-title 131
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS.
###end article-title 131
###begin article-title 132
The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins.
###end article-title 132
###begin article-title 133
Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli.
###end article-title 133
###begin article-title 134
SMN interacts with a novel family of hnRNP and spliceosomal proteins.
###end article-title 134
###begin p 135
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 135
###begin p 136
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by funds from Telethon-Italy (TCP 02011), "Compagnia di San Paolo" and the Muscular Dystrophy Association-USA to LP, Families of SMA to MERB, and NINDS (NS038650) to AHMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 136

